EUVIMEDObjevte EUVIMED
Crossref

Identification of a novel anti‐ROR1 nanobody through phage display and its biochemical characterization

Li Kang, Yingkui Dong, Wanxue Wang, Zehua Li, Yizhuo Wang, Li Yan, Cunlong Yin, XiaoHui Zhang, Han Dai, Bo Wu, Hongxin Zhao iD, Junfeng Wang

Biotechnology and Applied Biochemistry · 2024

DOI: 10.1002/bab.2623 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2024. Written by Li Kang and 11 co-authors. Institution: Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, China. Major MEDLINE topics: Receptor Tyrosine Kinase-like Orphan Receptors, Single-Domain Antibodies. Cited 1 times so far (Crossref); 28 references. Funded by: Anhui Major Basic Research Projects, Hefei Institutes of Physical Science Director's Fund.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

In this study, we aimed to develop nanobodies targeting receptor tyrosine kinase‐like orphan receptor 1 (ROR1) for cancer diagnosis and therapy. We immunized alpacas with ROR1, extracted RNA from their blood, and converted it to complementary DNA (cDNA) to amplify the VHH (variable domain of heavy‐chain antibodies) sequence. This sequence was used to construct a phage library with a capacity of 8 ×10 8 . Screening identified a high‐affinity nanobody, HCAbs1, which binds effectively to ROR1. ELISA and surface plasmon resonance analyses revealed HCAbs1's binding affinities to ROR1 at 4.42 and 12.9 nM, respectively. Functional tests showed HCAbs1 could reduce extracellular signal‐regulated kinase (ERK) phosphorylation levels induced by Wnt5a in ROR1‐transfected cells. Our findings highlight the potential of HCAbs1 nanobodies in diagnosing and treating cancers through targeting ROR1.

Subjects

MeSH terms (MEDLINE)

Receptor Tyrosine Kinase-like Orphan ReceptorsSingle-Domain AntibodiesHumansAnimalsCell Surface Display TechniquesPeptide LibraryCamelids, New World

Author keywords

ROR1Wnt5ananobodyphage display

Substances

Receptor Tyrosine Kinase-like Orphan ReceptorsSingle-Domain AntibodiesROR1 protein, humanPeptide Library

Authors and institutions

  • Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, China.
  • High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, China.
  • School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China.
  • University of Science and Technology of China, Hefei, Anhui, China.
  • College of Life Sciences, Anhui Normal University, Wuhu, Anhui, China.
  • Hefei China Science Longwood Biological Technology Co., Ltd, Hefei, Anhui, China.

ORCID profiles: Hongxin Zhao

Funding

  • Anhui Major Basic Research Projects
  • Hefei Institutes of Physical Science Director's Fund

Cite

APA

Kang, L., Dong, Y., Wang, W., Li, Z., Wang, Y., Yan, L., Yin, C., Zhang, X., Dai, H., Wu, B., Zhao, H., & Wang, J. (2024). Identification of a novel anti‐ROR1 nanobody through phage display and its biochemical characterization. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2623

Vancouver

Kang L, Dong Y, Wang W, Li Z, Wang Y, Yan L, et al. Identification of a novel anti‐ROR1 nanobody through phage display and its biochemical characterization. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2623

BibTeX
@article{Kang2024,
  author = {Kang, Li and Dong, Yingkui and Wang, Wanxue and Li, Zehua and Wang, Yizhuo and Yan, Li and Yin, Cunlong and Zhang, XiaoHui and Dai, Han and Wu, Bo and Zhao, Hongxin and Wang, Junfeng},
  title = {Identification of a novel anti‐ROR1 nanobody through phage display and its biochemical characterization},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2024},
  doi = {10.1002/bab.2623}
}
Start for free →